Commonwealth Equity Services
RVPH

Commonwealth Equity Services’s REVIVA PHARMA HLDGS INC RVPH Stock Holding History

Commonwealth Equity Services’s Portfolio RVPH Stock Details RVPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-1,813
Closed -$10.1K – 4430
2025
Q4 		$10.1K Buy
1,813
+800
+79% +$8.9K ﹤0.01% 4264
2025
Q3 		$7K Sell
1,013
-57
-5% -$484 ﹤0.01% 4227
2025
Q2 		$8K Buy
1,070
+200
+23% +$3.12K ﹤0.01% 4238
2025
Q1 		$17K Buy
870
+225
+35% +$7.07K ﹤0.01% 4133
2024
Q4 		$23K Buy
645
+28
+5% +$780 ﹤0.01% 4035
2024
Q3 		$18K Buy
+617
New +$13.7K ﹤0.01% 4006
2023
Q3 		– Sell
-669
Closed -$78K – 3916
2023
Q2 		$78K Buy
+669
New +$84.8K ﹤0.01% 3608

Other funds holding RVPH

Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
HCM
Highbridge Capital Management New York $3.09B AUM 31.21% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
WAM
Warberg Asset Management Winnetka, Illinois $551M AUM 34.68% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
VF
Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Commonwealth Equity Services's RVPH Position: Q1 2026 in Review

Commonwealth Equity Services sold out of REVIVA PHARMA HLDGS INC (RVPH) in Q1 2026, closing a stake of 1,813 shares — an estimated $10.1K sold.

Commonwealth Equity Services first reported a position in RVPH in Q2 2023 and held it in 7 quarters. The position peaked at $78K in Q2 2023. 35 funds tracked by Wall St. Rank hold RVPH as of Q1 2026.

  • Commonwealth Equity Services reported no remaining REVIVA PHARMA HLDGS INC position as of Q1 2026 after selling out during the quarter.
  • Commonwealth Equity Services sold 1,813 REVIVA PHARMA HLDGS INC shares in Q1 2026, an estimated $10.1K.
  • Commonwealth Equity Services first reported a position in REVIVA PHARMA HLDGS INC in Q2 2023 and held it in 7 quarters.
  • Commonwealth Equity Services's REVIVA PHARMA HLDGS INC position peaked at $78K in Q2 2023.
  • 35 funds tracked by Wall St. Rank held REVIVA PHARMA HLDGS INC as of Q1 2026.

Based on Commonwealth Equity Services's 13F filing for Q1 2026, filed 27 Apr 2026.